TRYP Therapeutics: Tryp Therapeutics Files Final Prospectus and Announces Initial Public Offering
Tryp or the
Company ) is pleased to announce that it has obtained a receipt for its final prospectus, which was filed with the securities regulatory authorities in the provinces of British Columbia, Alberta and Ontario on December 8, 2020 in connection with the initial public offering (the
Offering ) of 17,400,000 units of the Company (the
Units ) at a price of $0.25 per Unit. The aggregate gross proceeds of the Offering will be $4,350,000.
Each Unit consists of one common share in the capital of the Company (each a
Common Share )
Warrant ). Each Warrant is exercisable into one Common Share (each, a